WARD-Home - Continuous Monitoring of Vital Parameters After Discharge

Study Overview
=================
Brief Summary
-----------------
The current pilot study aims to investigate the feasibility of wireless, continuous monitoring of patients in the days around discharge after an acute medical hospitalization, as well as occurrence of deviating vital signs in this patient group.

Detailed Description
-----------------
The healthcare system is challenged by an aging patient population with chronic diseases, and acute admissions must be housed in hospitals with fewer beds and less staff resources. This increases the need for earlier discharge and for treatment shifted to the patients' own home. Furthermore, the transition from the hospital to the home setting is one of potential hazard, due to the lack of observation and intervention possibilities. This pilot study aims to investigate the feasibility of wireless, continuous monitoring of patients in the days around discharge after an acute medical hospitalization, as well as occurrence of deviating vital signs i in the patients' own homes during the first days after discharge.

Official Title
-----------------
WARD-Home - Continuous Monitoring of Vital Parameters for Early Detection of Complications in Patients Discharged After Acute Medical Hospitalization

Conditions
-----------------
Vital Sign, Clinical Deterioration

Intervention / Treatment
-----------------
* Device: Continuously monitoring


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Adult patients (≥18 years) Admitted with an acute medical disease and scheduled for discharge to their own homes within five days from inclusion. Exclusion Criteria: Allergy to plaster, plastic, or silicone. A pacemaker or Implantable Cardioverter Defibrillator (ICD) device. If the patient was deemed not able to open the front door when visited by the investigator. Inability to give informed consent.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Observed patients<br>Adult patients (≥18 years) admitted with an acute medical disease and who are scheduled for discharge to their own homes within five days from inclusion. | Device: Continuously monitoring<br>* Included patients are monitored with WARD equipment during the last part of hospitalization and the first days after discharge. Monitoring will last for a maximum of eight days.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Duration of data collection from the Lifetouch patch |  | Up to 8 days of monitoring | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Duration of complete peripheral saturation data |  | Up to 8 days of monitoring | 
| Duration of complete blood pressure data |  | Up to 8 days of monitoring | 
| Cummulated duration of desaturation | Peripheral saturation below 88% and 85% | Up to 8 days of monitoring | 
| Number of events with SpO2 < 88% in at least 10 consecutive minutes |  | Up to 8 days of monitoring | 
| Number of events with SpO2 < 85% in at least 5 consecutive minutes |  | Up to 8 days of monitoring | 
| Number of deviating vital parameters in accordance to defined microevents |  | Up to 8 days of monitoring |